Vivani posts Jefferies conference investor slides

Vivani Medical, Inc. is providing an informational update by sharing an investor slide presentation in connection with its appearance at the Jefferies Global Healthcare Conference in New York.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Vivani Medical, Inc. is providing an informational update by sharing an investor slide presentation in connection with its appearance at the Jefferies Global Healthcare Conference in New York. The company plans to present on June 4, 2026 at 11:05 a.m. Eastern, and the slides are available as Exhibit 99.1 and on the Investors section of its website.

The company notes that the slide deck speaks only as of its date and that Vivani has no obligation to update it, even if circumstances change. The information in this communication is being furnished under Regulation FD and is not deemed filed for liability purposes under the securities laws.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Conference presentation time: 11:05 a.m. Eastern Presentation date: June 4, 2026

2 metrics

Conference presentation time 11:05 a.m. Eastern Jefferies Global Healthcare Conference on June 4, 2026

Presentation date June 4, 2026 Date of Vivani slide presentation Exhibit 99.1

Key Terms

Regulation FD, emerging growth company, Exhibit 99.1, Inline XBRL

4 terms

Regulation FD regulatory

"Item 7.01. Regulation FD Disclosure. Vivani Medical, Inc., or Vivani, will make a presentation"

Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.

emerging growth company regulatory

"Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Exhibit 99.1 regulatory

"A copy of a slide presentation ... is attached ... as Exhibit 99.1 and is incorporated"

Exhibit 99.1 is a label used in regulatory filings to identify a specific attached document, most often a company press release or investor presentation filed with securities regulators. For investors it matters because it marks an official, contemporaneous source of information directly tied to a filing—like the original news article pinned to a legal record—so traders and analysts treat it as an authoritative statement that can move a stock or clarify a company’s situation.

Inline XBRL technical

"104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vivani (VANI) disclose in this 8-K filing?

Vivani furnished an investor slide presentation linked to its appearance at the Jefferies Global Healthcare Conference. The slides are attached as Exhibit 99.1 and posted on its investor website, but are treated as furnished, not filed, under securities laws.

When is Vivani (VANI) presenting at the Jefferies Global Healthcare Conference?

Vivani plans to present at the Jefferies Global Healthcare Conference in New York on June 4, 2026 at 11:05 a.m. Eastern. The company’s CEO, Dr. Adam Mendelsohn, intends to use the posted slide deck.

Where can investors access Vivani’s June 4, 2026 slide presentation?

Investors can view Vivani’s slide presentation as Exhibit 99.1 to the 8-K and on the Investors section of the company’s website. The presentation is dated June 4, 2026 and supports the Jefferies conference appearance.

Is Vivani’s Jefferies conference presentation considered filed with the SEC?

No. Vivani states the information in Item 7.01 and Exhibit 99.1 is furnished, not filed, under the Exchange Act. This limits potential liability under Section 18 unless the presentation is expressly incorporated into another SEC filing.

Does Vivani (VANI) have to update the June 4, 2026 slide deck?

Vivani explains the slide presentation speaks only as of its date and specifically disclaims any obligation to update it. The company may choose to revise it later, but is not committing to do so in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/04/2026 - 07:30 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 4, 2026

Vivani Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-36747

02-0692322

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1350 S. Loop Road Alameda, California	94502
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (415) 506-8462

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		VANI		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

Vivani Medical, Inc., or Vivani, will make a presentation at the Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026 at 11:05 a.m. Eastern. A copy of a slide presentation that Dr. Adam Mendelsohn, Vivani’s Chief Executive Officer intends to use during the conference is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein. Vivani is also posting to the “Investors” portion of its website a copy of the slide presentation. The slide presentation speaks only as of the date of this Current Report on Form 8-K. While Vivani may elect to update the slide presentation in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Vivani specifically disclaims any obligation to do so.

The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Vivani Medical, Inc. slide presentation dated June 4, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.